Skip to main content

Immunosuppression: Coronavirus

Question for Department of Health and Social Care

UIN 140427, tabled on 15 March 2022

To ask the Secretary of State for Health and Social Care, whether his Department holds any list of patients who have been identified as immunocompromised and are eligible for new covid-19 treatments first announced in December 2021; and whether such a list includes the addresses of those patients.

This answer is the replacement for a previous holding answer.

Answered on

21 March 2022

The Department commissioned an independent expert group to identify clinically eligible patient cohorts most likely to progress towards developing severe COVID-19. These cohorts form part of an evidence-based clinical policy for the treatment of COVID-19, agreed by the United Kingdom Chief Medical Officers. The treatments available include the monoclonal antibody therapy sotrovimab, as well as the oral antiviral treatments molnupiravir and nirmatrelvir + ritonavir.

The Department does not hold a list of these patients, nor any identifiable personal information.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.